Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients

We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahine, Johnny, Collier, Patrick, Maroo, Anjli, Tang, W.H. Wilson, Klein, Allan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Focus Issue: Myocardial and Pericardial Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298653/
https://www.ncbi.nlm.nih.gov/pubmed/34317203
http://dx.doi.org/10.1016/j.jaccas.2019.11.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298653/
https://www.ncbi.nlm.nih.gov/pubmed/34317203
http://dx.doi.org/10.1016/j.jaccas.2019.11.080

Ejemplares similares